Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 11 Issue 10 Pages: 8707-8723 Pub: 2020 Oct 21 Epub: Authors Mu J , Tan F , Zhou X , Zhao X , |
|
|
Purification and characterization of a component produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus. ✅
The Journal of applied bacteriology (J Appl Bacteriol ) Vol: 80 Issue 3 Pages: 311-8 Pub: 1996 Mar Epub: Authors Ouwehand AC , Conway PL , |
|
|
Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: Issue Pages: 105471 Pub: 2021 Jan 30 Epub: 2021 Jan 30 Authors Molina-Tijeras JA , Diez-Echave P , Vezza T , Hidalgo-García L , Ruiz-Malagón AJ , Rodríguez-Sojo MJ , Romero M , Robles-Vera I , García F , Plaza-Diaz J , Olivares M , Duarte J , Rodríguez-Cabezas ME , Rodríguez-Nogales A , Gálvez J , |
|
|
Effects of Dietary Limosilactobacillus fermentum and Lacticaseibacillus paracasei Supplementation on the Intestinal Stem Cell Proliferation, Immunity, and Ileal Microbiota of Broiler Chickens Challenged by Coccidia and Clostridium perfringens. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 13 Issue 24 Pages: Pub: 2023 Dec 15 Epub: 2023 Dec 15 Authors Guo S , Tong W , Qi Y , Jiang M , Li P , Zhang Z , Hu Q , Song Z , Ding B , |
|
|
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota. ✅
Go to Publication ✅
Microbial cell factories (Microb Cell Fact ) Vol: 22 Issue 1 Pages: 256 Pub: 2023 Dec 12 Epub: 2023 Dec 12 Authors Kaur S , Sharma P , Mayer MJ , Neuert S , Narbad A , Kaur S , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 16 Issue 5 Pages: 1773-1789 Pub: 2024 Oct Epub: 2023 Aug 10 Authors da Silva JYP , do Nascimento HMA , de Albuquerque TMR , Sampaio KB , Dos Santos Lima M , Monteiro M , Leite IB , da Silva EF , do Nascimento YM , da Silva MS , Tavares JF , de Brito Alves JL , de Oliveira MEG , de Souza EL , |
|
|
Lactobacillus fermentum V3 ameliorates colitis-associated tumorigenesis by modulating the gut microbiome. ✅
American journal of cancer research (Am J Cancer Res ) Vol: 10 Issue 4 Pages: 1170-1181 Pub: 2020 Epub: 2020 Apr 1 Authors Chou YC , Ho PY , Chen WJ , Wu SH , Pan MH , |
|
|
Lactobacillus fermentum and Lactobacillus plantarum increased gut microbiota diversity and functionality, and mitigated Enterobacteriaceae, in a mouse model. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 4 Pages: 413-424 Pub: 2019 Apr 19 Epub: 2019 Apr 8 Authors Linninge C , Xu J , Bahl MI , Ahrné S , Molin G , |
|
|
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
